OraSure to Present at J.P Morgan Healthcare Conference

J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health and pharmaceutical sectors.
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer of Recludix,
Labcorp to Participate in J.P. Morgan Healthcare Conference
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your
Samsung, Celltrion to exhibit at J.P. Morgan Healthcare Conference
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
Marengo Therapeutics To Present At The 43Rd Annual J.P. Morgan Healthcare Conference
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision T cell activation, today announced that Zhen Su, M.D., MBA, the Company's Chief Executive Officer,
OraSure to Present at the J.P Morgan Healthcare Conference
About OraSure Technologies, Inc. OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access,
M&A, obesity top of mind for investors at J.P. Morgan Healthcare conference: Portal Innovations CEO
John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...
manilatimes17h
Pulmocide Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Pulmocide Ltd., ("the Company”), a late-stage biopharmaceutical company developing inhaled opelconazole for patients suffering from ser ...
Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
The panel will discuss the value proposition for investing in women’s health. J.P. Morgan is hosting a three-panel women’s ...
Business Wire4d
Ensem Therapeutics Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Ensem Therapeutics, Inc. (ENSEM), a pioneering drug discovery and development company that leverages its unique Kinetic ...